PREOPANC2 is a great ex of ignoring data that doesn't fit one's priors. Many (myself included) were surprised by results, but it's a Ph3 RCT & data are the data. Gem-based RT is cheaper, less toxic than FFX; future trials should consider building off this regimen as baseline.

Tri fantastična dana na 57. Kongresu EPC-a. Više od profesionalnog okupljanja — velika porodica lekara posvećenih pankreasu. Nadam se još mnogo ovakvih trenutaka druženja i nauke,ne samo sa kolegama, već i sa doživotnim prijateljima. @Shrikhande_SV @Gio_Marchegiani @EurPancClub

Prof Buchler @ChampalimaudF gives his “Lessons For Young Surgeons” and his “Lessons For The Teachers” at the @EurPancClub #EPC2025. A living legend 👑 in #Pancreas #Surgery

Najveći evropksi kongres posvećen hirurgiji jetre, pankreasa i zucnih puteva u istoriji. Najviše ucesnika iz Srbije (19) do sada. Donesen je novi evropski vodic za lecenje karcinoma pankreasa,u cijoj izradi sam imao cast da učestvujem. Divna razmena znanja, iskustva uz druzenje.

Local chapters presidents breakfast #EAHPBA25 with the European-African Hepato-Pancreato-Biliary Association (E-AHPBA) Germany 🇩🇪 Zwitserland 🇨🇭 The Netherlands 🇳🇱 Czechia 🇨🇿 Austria 🇦🇹 Italy 🇮🇹 West-East Balkan 🇷🇸 🇸🇮 🇭🇷 🇧🇬 ao Spain 🇪🇸 With the new president Eduard Jonas

Start of the 2025 European Multi-Societal European Guideline on #PancreaticCancer #EAHPBA25 ✅ 60.000+ articles reviewed ✅ 39 systematic reviews by 13 groups ✅ 111 PhDs, fellows, experts involved ✅ 30 European societies ✅ incl 5 patient organizations ✅ focus on research gaps

☘️ We are ready to welcome 🤗 you in Dublin 🇮🇪 for a glorious @EAHPBA 2025!!! Stay tuned for 4 days of science, surgery and friendship!

🇮🇹CASSANDRA TRIAL🇮🇹 Phase 3 RCT: Neoadjuvant PAXG vs mFOLFIRINOX in resectable/BR #PDAC 💥PAXG shows: ✅⬆️EFS ✅⬆️Path response ✅Suggestion of ⬆️OS ✅Same toxicity PAXG superior to mFOLFIRINOX? @IHPBA @EurPancClub @EAHPBA @OncoAlert @OfficialPCA @Oncoinfo_it @hpb_so

Full Circle Moment From a postdoctoral fellow in 2007 to Visiting Professor —an incredible honor to give my Inauguration Lecture at the University of Heidelberg @surgery_hps! Grateful and excited for what’s ahead. @cw_michalski @bkinnykoester @ThomasHankMD @Mo_Saeedi_Surg

Great “kick off “ of our regional HPB meeting @EAHPBA @carlijnbuis

Relationship between resection rate and survival in pancreatic cancer *at population-level* by @elockie18&al @BjsOpen 👉The more you resect the better survival for the whole population 👉Efforts to increase the resection rate Commentary by @chiaro_del&al Links👇

Honored for the podium for the State of the Art Lecture @AHPBA in Miami. Great interest toward the innovation we introduced in liver surgery. @HumanitasMilano @HUNIMED @IHPBA @EAHPBA @APHPBA @SSATNews @IASGO_1988

Is there a role for neoadjuvant chemo for 🍇 invasive IPMN ?! 🌎 1k resected only 7% after NAT 👍 BR / LAPC no worse OS after NAT 🧪 CA19.9 indicates “biological” treatment effect 👉 https://t.co/tyP098glrq

Preoperative stereotactic radiotherapy to prevent pancreatic fistula in high-risk patients undergoing pancreatoduodenectomy (FIBROPANC): prospective multicentre phase II single-arm trial ➡️ https://t.co/0CWPPArooc The FIBROPANC study investigated the safety, feasibility, and

Can prophylactic #Radiotherapy #SBRT in non-PDAC #pancreatoduodenectomy prevent fistula POPF? ▶️#FIBROPANC published today @BJS 🔑 “it works but it doesn’t help” https://t.co/tyIuuKpGpb

Congratulations to the inaugural meeting of the #TransCaspian HPB Association. Excellent work of @MKeremDr & colleagues. ✅ On behalf of @EAHPBA: welcome in our family! ✅ Through @EAHPBA you are now also included in the @IHPBA family 🌍 🙏 @iisifrigerio @Gio_Marchegiani

16-ti Kongres Udruzenja endoskopskih hirurga Slovenije. Još jedna prilika za razmenu iskustava i druzenje sa dragim kolegama iz regiona. Velika zahvalnost organizatorima na više nego ljubaznom pozivu da odrzim predavanje o minimalno inavazivnoj hirurgiji pankreasa.

🚨 Abstract Submission Deadline Reminder! Submit by 9th January 2025 for the 16th E-AHPBA Biennial Congress in Dublin! Visit https://t.co/eclQ0n6tzq to submit your abstract now! 🗓️ Congress Dates: 9th June 2025: Pre-Congress Courses 10th - 12th June 2025: Main

“So, a soft pancreas ➡️ main driver of fistula ➡️ majority of deaths in #Whipple #surgery”📛 💡 “What if we use #SBRT to induce fibrosis preop in non-PDAC (!) pts. Would it work? Could we prevent POPF?”✅ Did anybody try this before?? ☢️ Happening now in the #FIBROPANC pilot

Distinct clinical outcomes & biological features of specific KRAS mutants in human pancreatic cancer @Cancer_Cell https://t.co/7S6LsqbSKV 👉KRASG12R enriched in early stage w/ reduced nodal disease + distant recurrence 👉improved OS 🧐 Supports KRAS mutational testing in #PDAC